Trials that use: P-values
New to this method? Read the tutorial →
10,701 results
- GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma: Complete Statistical AnalysisIndependent statistical analysis of GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- GSK1120212+GSK2141795 for Cervical Cancer: Complete Statistical AnalysisIndependent statistical analysis of GSK1120212+GSK2141795 for Cervical Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01958112).
- GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asia: Complete Statistical AnalysisIndependent statistical analysis of GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asia: primary endpoint results, effect estimate…
- GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary Disease: Complete Statistical AnalysisIndependent statistical analysis of GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00950807).
- guardian™ 3Independent statistical analysis of Safety and Efficacy of Turoctocog Alfa in Previously Treated Male Children With Haemophilia A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- GUIDE-ITIndependent statistical analysis of Guiding Evidence Based Therapy Using Biomarker Intensified Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01685840).
- GUIDEDIndependent statistical analysis of Genomics Used to Improve DEpression Decisions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02109939).
- GuidePathIndependent statistical analysis of Study of Diagnostic Performance of [18F]CTT1057 in BCR: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04838613).
- Gulf War Digestive Health Study: Complete Statistical AnalysisIndependent statistical analysis of Gulf War Digestive Health Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00680836).
- gustinpropIndependent statistical analysis of Gustin Gene Polymorphism and 6-n-propylthiouracil (PROP) Taste: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01097915).
- Gut Microbiome & Gastrointestinal Toxicities as Determinants of Response to Neoadjuvant Chemo for Advanced Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Gut Microbiome & Gastrointestinal Toxicities as Determinants of Response to Neoadjuvant Chemo for Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Gut Organoid and Microbiome Interactions in Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Gut Organoid and Microbiome Interactions in Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04497727).
- GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- GVHD ASEDIndependent statistical analysis of A Randomized, Controlled, Double-Masked, Clinical Trial of Autologous Serum Eye Drops for Severe Ocular Chronic Graft-versus-Host Disease (GVHD) in Hematopoietic Stem Cell Transplant (HSCT) Patients: primary endpoint results,…
- GWIIRTIndependent statistical analysis of Gulf War Illness Inflammation Reduction Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02506192).
- GWINISIndependent statistical analysis of Gulf War Illness Nasal Irrigation Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01700725).
- GWPCARE5Independent statistical analysis of An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Adults With Dravet or Lennox-Gastaut Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- H2HIndependent statistical analysis of Study to Compare 2 Botulinum Type A Toxins in the Treatment of Glabellar Frown Lines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- H3MIndependent statistical analysis of Healthy Hearts Healthy Minds: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03373110).
- H42/H4UIndependent statistical analysis of Pragmatic Randomized Clinical Trial to Limit Weight Gain in Pregnancy and Prevent Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- HA vs PRPIndependent statistical analysis of Hyaluronic Acid vs Platelet Rich Plasma: Effects on Clinical Outcomes and Intra-articular Biology for the Treatment of Knee Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size…
- HABITSIndependent statistical analysis of Healthy Homes, Healthy Habits: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03433456).
- HAI115879Independent statistical analysis of Dose Ranging of GSK2336805 in Combination Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01648140).
- HALOIndependent statistical analysis of A Study of CIN-107 in Patients With Uncontrolled Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05137002).
- HALO Patient Registry: Ablation of Barrett’s Esophagus: Complete Statistical AnalysisIndependent statistical analysis of HALO Patient Registry: Ablation of Barrett's Esophagus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00848237).
- HALT PKD AIndependent statistical analysis of HALT Progression of Polycystic Kidney Disease Study A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00283686).
- HALT-DIndependent statistical analysis of Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- HAMIndependent statistical analysis of Sleep Length and Circadian Regulation in Humans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00843843).
- Hand Therapy Intervention Versus Traditional Occupational Therapy to Prevent Chemotherapy Induced Peripheral Neuropathy: Complete Statistical AnalysisIndependent statistical analysis of Hand Therapy Intervention Versus Traditional Occupational Therapy to Prevent Chemotherapy Induced Peripheral Neuropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Hand-carried Ultrasound to Assess Hydronephrosis: Complete Statistical AnalysisIndependent statistical analysis of Hand-carried Ultrasound to Assess Hydronephrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03774719).
- Handgrip Exercise for Arteriovenous Fistula Maturation: Complete Statistical AnalysisIndependent statistical analysis of Handgrip Exercise for Arteriovenous Fistula Maturation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01061008).
- Handheld Ultrasound Evaluation of the Inferior Vena Cava to Guide Heart Failure Treatment: Complete Statistical AnalysisIndependent statistical analysis of Handheld Ultrasound Evaluation of the Inferior Vena Cava to Guide Heart Failure Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- HANDmacIndependent statistical analysis of A Study of the Neurological Effects of Adding Maraviroc to HAART Regimen in Patients With HIV (HANDmac): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- HAPIIndependent statistical analysis of HIV And Parasitic Infection (HAPI) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05323396).
- Haplo/CordIndependent statistical analysis of Hematopoietic Stem Cell Transplantation (HSCT) Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells: Complete Statistical AnalysisIndependent statistical analysis of Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01050764).
- HARBOURIndependent statistical analysis of Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL): primary endpoint results, effect…
- Harmonic Scalpel Vs. Electrocautery in Breast Reduction Surgery: Complete Statistical AnalysisIndependent statistical analysis of Harmonic Scalpel Vs. Electrocautery in Breast Reduction Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00819260).
- HARMONIZE GLIndependent statistical analysis of A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Harmony at Home: A Pilot Telehealth Program for Rural ADRD Caregivers: Complete Statistical AnalysisIndependent statistical analysis of Harmony at Home: A Pilot Telehealth Program for Rural ADRD Caregivers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- HARPIndependent statistical analysis of Home Hazard Removal Program to Reduce Falls: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02392013).
- HBMT IIIndependent statistical analysis of Hostile Bias Modification Training Online Study II: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04015440).
- HCQ on PAR-4 Levels in Patients With Resectable Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of HCQ on PAR-4 Levels in Patients With Resectable Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02232243).
- HCVIndependent statistical analysis of An Integrated Care Model for Improving Hepatitis C Virus Patient Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- HCV-RNA Kinetics During Sorafenib for Hepatocellular Carcinoma (HCC): Complete Statistical AnalysisIndependent statistical analysis of HCV-RNA Kinetics During Sorafenib for Hepatocellular Carcinoma (HCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01849588).
- HCW9218 in Select Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of HCW9218 in Select Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05322408).
- HD-LIPTIndependent statistical analysis of High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- HDIL2/EmendIndependent statistical analysis of Fosaprepitant for N/V With High-dose Interleukin-2 for Metastatic Melanoma and Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- HDLIndependent statistical analysis of High Dose Lurasidone for Patients With Treatment Resistant Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01569659).
- HDtDCS in Logopenic Variant PPA: Effects on Language and Neural Mechanisms: Complete Statistical AnalysisIndependent statistical analysis of HDtDCS in Logopenic Variant PPA: Effects on Language and Neural Mechanisms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…